S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
66,000% upside on tiny biotech? (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
66,000% upside on tiny biotech? (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
66,000% upside on tiny biotech? (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
66,000% upside on tiny biotech? (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
NYSE:RAD

Rite Aid (RAD) Stock Forecast, Price & News

$1.82
-0.01 (-0.54%)
(As of 06/5/2023 ET)
Compare
Today's Range
$1.80
$1.90
50-Day Range
$1.76
$2.63
52-Week Range
$1.67
$11.61
Volume
1.13 million shs
Average Volume
1.63 million shs
Market Capitalization
$102.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.75

Rite Aid MarketRank™ Forecast

Analyst Rating
Reduce
1.00 Rating Score
Upside/​Downside
50.7% Upside
$2.75 Price Target
Short Interest
Bearish
27.47% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.85
Upright™ Environmental Score
News Sentiment
0.68mentions of Rite Aid in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($4.81) to ($4.39) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.45 out of 5 stars

Retail/Wholesale Sector

191st out of 204 stocks

Drug Stores & Proprietary Stores Industry

5th out of 6 stocks


RAD stock logo

About Rite Aid (NYSE:RAD) Stock

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Receive RAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rite Aid and its competitors with MarketBeat's FREE daily newsletter.

RAD Stock News Headlines

“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Rite Aid (NYSE:RAD) Issues FY 2024 Earnings Guidance
Rite Aid (NYSE:RAD) Upgraded to Hold at StockNews.com
Q4 2023 Rite Aid Corp Earnings Call
See More Headlines

RAD Price History

RAD Company Calendar

Last Earnings
4/20/2023
Today
6/05/2023
Next Earnings (Estimated)
6/22/2023
Fiscal Year End
2/29/2024

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
CUSIP
76775410
Employees
47,000
Year Founded
1968

Price Target and Rating

Average Stock Price Forecast
$2.75
High Stock Price Forecast
$4.50
Low Stock Price Forecast
$1.00
Forecasted Upside/Downside
+50.7%
Consensus Rating
Reduce
Rating Score (0-4)
1.00
Research Coverage
2 Analysts

Profitability

Net Income
$-749,940,000.00
Pretax Margin
-3.14%

Debt

Sales & Book Value

Annual Sales
$24.09 billion
Cash Flow
$1.81 per share
Book Value
($11.35) per share

Miscellaneous

Free Float
55,152,000
Market Cap
$102.98 million
Optionable
Optionable
Beta
1.11

Social Links


Key Executives

  • Elizabeth Burr
    Chief Executive Officer & Director
  • Matthew C. Schroeder
    Chief Financial Officer & Executive Vice President
  • Justin Mennen
    Chief Digital & Technology Officer
  • Jessica Kazmaier
    Chief Human Resources Officer & Executive VP
  • Andre Persaud
    Chief Retail Officer & Executive Vice President













RAD Stock - Frequently Asked Questions

Should I buy or sell Rite Aid stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last twelve months. There are currently 2 sell ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" RAD shares.
View RAD analyst ratings
or view top-rated stocks.

What is Rite Aid's stock price forecast for 2023?

2 brokerages have issued 12 month price targets for Rite Aid's stock. Their RAD share price forecasts range from $1.00 to $4.50. On average, they anticipate the company's stock price to reach $2.75 in the next year. This suggests a possible upside of 50.7% from the stock's current price.
View analysts price targets for RAD
or view top-rated stocks among Wall Street analysts.

How have RAD shares performed in 2023?

Rite Aid's stock was trading at $3.34 at the start of the year. Since then, RAD stock has decreased by 45.4% and is now trading at $1.8250.
View the best growth stocks for 2023 here
.

When is Rite Aid's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 22nd 2023.
View our RAD earnings forecast
.

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) announced its quarterly earnings results on Thursday, April, 20th. The company reported ($1.24) EPS for the quarter, missing analysts' consensus estimates of ($0.77) by $0.47. The business had revenue of $6.09 billion for the quarter, compared to analysts' expectations of $5.70 billion. The business's quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($1.63) EPS.

When did Rite Aid's stock split?

Rite Aid shares reverse split on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 19th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid updated its FY24 earnings guidance on Thursday, April, 20th. The company provided earnings per share (EPS) guidance of ($4.93)-($4.44) for the period, compared to the consensus estimate of ($1.84). The company issued revenue guidance of $21.7-22.1 billion, compared to the consensus revenue estimate of $20.88 billion.

What is Heyward Donigan's approval rating as Rite Aid's CEO?

169 employees have rated Rite Aid Chief Executive Officer Heyward Donigan on Glassdoor.com. Heyward Donigan has an approval rating of 58% among the company's employees. This puts Heyward Donigan in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Bank of America (BAC), Akorn (AKRX), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF), Mr. Cooper Group (COOP), General Electric (GE), Micron Technology (MU) and CVS Health (CVS).

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

Who are Rite Aid's major shareholders?

Rite Aid's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.94%), Charles Schwab Investment Management Inc. (6.26%), Boothbay Fund Management LLC (0.00%), GMT Capital Corp (2.63%), Geode Capital Management LLC (1.83%) and Renaissance Technologies LLC (1.75%). Insiders that own company stock include Heyward R Donigan and Jocelyn Z Konrad.
View institutional ownership trends
.

How do I buy shares of Rite Aid?

Shares of RAD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $1.83.

How much money does Rite Aid make?

Rite Aid (NYSE:RAD) has a market capitalization of $102.98 million and generates $24.09 billion in revenue each year. The company earns $-749,940,000.00 in net income (profit) each year or ($13.72) on an earnings per share basis.

How many employees does Rite Aid have?

The company employs 47,000 workers across the globe.

Does Rite Aid have any subsidiaries?
The following companies are subsidiares of Rite Aid: 1515 West State Street Boise Idaho  LLC, 1740 Associates  LLC, 4042 Warrensville Center Road—Warrensville Ohio  Inc., 5277 Associates  Inc., 5600 Superior Properties  Inc., Advance Benefits  LLC, Apex Drug Stores  Inc., Ascend Health Technology  LLC, Bartell Drugs, Broadview and Wallings—Broadview Heights Ohio  Inc., Design Rx Holdings  LLC, Design Rx  LLC, Design Rxclusives  LLC, Drug Palace Inc., EDC Drug Stores  Inc., Eckerd Corporation, Edgehill Drugs, Elixir Holdings LLC, Elixir Insurance Company, Elixir Pharmacy LLC, Elixir Puerto Rico  Inc., Elixir Rx Options  LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions of Nevada  LLC, Elixir Rx Solutions  LLC, Elixir Savings  LLC, Envision Pharmaceutical, First Florida Insurers of Tampa  LLC, GDF  Inc., Genovese Drug Stores  Inc., Gettysburg and Hoover-Dayton Ohio LLC, Grand River & Fenkell LLC, Harco, Harco  Inc., Health Dialog, Health Dialog Services Corporation, Hunter Lane  LLC, ILG – 90 B Avenue Lake Oswego LLC, JCG Holdings USA  Inc., JCG PJC USA  LLC, K&B Alabama Corporation, K&B Incorporated, K&B Industries, K&B Louisiana Corporation, K&B Mississippi Corporation, K&B Services Incorporated, K&B Tennessee Corporation, K&B Texas Corporation, LMW – 90B Avenue Lake Oswego Inc., Lakehurst and Broadway Corporation, Laker Software  LLC, Maxi Drug North  Inc., Maxi Drug South  L.P., Maxi Drug  Inc., Maxi Green  Inc., Munson & Andrews  LLC, Name Rite  LLC, P.J.C. Distribution  Inc., P.J.C. Realty Co.  Inc., PCS Health Systems, PDS-1 Michigan  Inc., PJC Lease Holdings  Inc., PJC Manchester Realty LLC, PJC Peterborough Realty LLC, PJC Realty MA  Inc., PJC Revere Realty LLC, PJC Special Realty Holdings  Inc., PJC of Massachusetts  Inc., PJC of Rhode Island  Inc., PJC of Vermont  Inc., Perry Distributors  Inc., Perry Drug Stores Inc., RCMH  LLC, RDS Detroit  Inc., READ’s Inc., RediClinic, RediClinic Associates  Inc., RediClinic US LLC, RediClinic of DC LLC, RediClinic of DE LLC, RediClinic of Dallas Forth-Worth LLC, RediClinic of MD LLC, RediClinic of PA  LLC, RediClinic of VA LLC, RediClinic LLC, Richfield Road – Flint Michigan LLC, Rite Aid Drug Palace  Inc., Rite Aid Hdqtrs. Corp., Rite Aid Hdqtrs. Funding  Inc., Rite Aid Lease Management Company, Rite Aid Online Store Inc., Rite Aid Payroll Management Inc., Rite Aid Realty Corp., Rite Aid Rome Distribution Center  Inc., Rite Aid Specialty Pharmacy LLC, Rite Aid Transport  Inc., Rite Aid of Connecticut  Inc., Rite Aid of Delaware  Inc., Rite Aid of Georgia  Inc., Rite Aid of Indiana  Inc., Rite Aid of Kentucky  Inc., Rite Aid of Maine  Inc., Rite Aid of Maryland  Inc., Rite Aid of Michigan  Inc., Rite Aid of New Hampshire  Inc., Rite Aid of New Jersey  Inc., Rite Aid of New York  Inc., Rite Aid of North Carolina  Inc., Rite Aid of Ohio  Inc., Rite Aid of Pennsylvania  LLC, Rite Aid of South Carolina  Inc., Rite Aid of Tennessee  Inc., Rite Aid of Vermont  Inc., Rite Aid of Virginia  Inc., Rite Aid of Washington D.C.  Inc., Rite Aid of West Virginia  Inc., Rite Investments Corp., Rite Investments Corp.  LLC, Rx Choice  Inc., Rx Initiatives  LLC, Rx USA Inc., The Bartell Drug Company, The Jean Coutu Group PJC USA  Inc., The Lane Drug Company, Thrift Drug Inc., Thrifty Corporation, Thrifty PayLess  Inc., and Tonic Procurement Solutions LLC.
Read More
How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The official website for the company is www.riteaid.com. The company can be reached via phone at (717) 761-2633, via email at investor@riteaid.com, or via fax at 717-975-5871.

This page (NYSE:RAD) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -